fda warning letter compounding semaglutide october 2025 The sent a to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know Three Considerations When Prescribing Compounded

No stomach contents that might cause nausea when combined with a GLP-1 agonist

There is a paucity of clinical evidence assessing the association between weight loss medications and migraine headache

the combination according to the invention can be marketed as a food supplement, a nutritional supplement, or as a therapeutic product on sale with or without a compulsory doctor's prescription

Most of the time, surgery is straightforward

However, when compounded medications are marketed broadly and sold directly to consumers, they may fall outside the scope of traditional pharmacy practice and into potential legal jeopardy

No noticeable changes were observed for mean diastolic blood pressure